Home » Topics » Disease categories and therapies » Immune

Immune
RSS

New cathepsin S inhibitors designed by Boehringer Ingelheim researchers

Aug. 21, 2002

Wyeth scientists identify novel inhibitors of B7.1-CD28 interaction

Aug. 21, 2002

CAT and Xerion enter allergy target research collaboration

Aug. 21, 2002

ProdiGene and NIAID to begin phase I trial of oral traveler's diarrhea vaccine

Aug. 20, 2002

Novel ITK tyrosine kinase inhibitors and their use covered by BMS patent

Aug. 13, 2002

Crucell and NIAID expand Ebola vaccine agreement to include Marburg and Lassa vaccines

Aug. 13, 2002

Adjuvant QS-21 enhances immunogenicity of malaria peptide vaccine

Aug. 6, 2002

Zonagen receives SBIR grant to study adjuvant system

Aug. 5, 2002

Marketing authorization for Triacelluvax withdrawn in E.U.

Aug. 5, 2002

New formulation of Rapamune introduced in U.K.

July 26, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.